Stanley Qi, Kristen Brennand, Luke Gilbert, and more at CRISPR: New Techniques and Complex Models virtual event

20 views
Skip to first unread message

Virtual Post Bioclues

unread,
Jun 10, 2021, 7:42:50 AM6/10/21
to bioc...@googlegroups.com
CRISPR New Techniques and Complex Models

CRISPR: New Techniques and Complex Models
June 30, 2021
12pm – 4pm EDT

Register Now btn

CRISPR: New Techniques and Complex Models is a free, half-day virtual event that brings together some of the world’s leading experts to discuss new methods that take CRISPR beyond gene editing and how they can be applied to complex cellular systems.

Distinguished Keynote and Plenary Speakers

Anna Moreno, PhD
Anna Moreno, PhD
Founder & CEO
Navega Therapeutics

Stanley Qi, PhD
Stanley Qi, PhD
Assistant Professor
Department of Bioengineering
Department of Chemical and Systems Biology
Stanford ChEM-H Institute

Stanley Qi, PhD
Kristen Brennand, PhD
Faculty Member
Yale School of Medicine

Shondra Pruett-Miller, PhD
Shondra Pruett-Miller, PhD
Assistant Member, St. Jude Faculty
Director, Center for Advanced Genome Engineering
Associate Director, Shared Resources, Comprehensive Cancer Center
St. Jude Children's Research Hospital

Tyler Goralski, PhD
Luke Gilbert, PhD
Assistant Professor
Helen Diller Family Comprehensive Cancer Center
School of Medicine
Department of Urology
University of California San Francisco

Attendees will get exclusive access to hear and interact with our speakers as they discuss:

  • Clinical and research applications of CRISPR modulation (CRISPRa & CRISPRi) methods
  • Harnessing the flexibility of editing iPSCs for various end-state cell types
  • Validating results of CRISPR screens using orthogonal validation methods
  • Generating heritable, epigenetic changes using CRISPRoff

Plus ask questions live, get real-time feedback, and participate in state-of-the-art networking with fellow attendees — all through our dynamic virtual platform accessible on all devices, at home or on-the-go!

Register Now btn

 

Brought to you by The CRISPR Journal and Genetic Engineering & Biotechnology News (GEN) in partnership with Horizon

Logos



Reply all
Reply to author
Forward
0 new messages